Pregnancy incidence and outcomes in women with perinatal HIV infection.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28590327)

Published in AIDS on June 05, 2017

Authors

Laura Byrne1, Rebecca Sconza, Caroline Foster, Pat A Tookey, Mario Cortina-Borja, Claire Thorne

Author Affiliations

1: aUCL Great Ormond Street Institute of Child Health bImperial College Healthcare NHS Trust, London, UK.

Articles cited by this

A Wilcoxon-type test for trend. Stat Med (1985) 13.22

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS (2008) 4.48

Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis (2007) 2.35

Trends in management and outcome of pregnancies in HIV-infected women in the UK and Ireland, 1990-2006. BJOG (2008) 2.09

Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS (2011) 1.66

Reproductive health of adolescent girls perinatally infected with HIV. Am J Public Health (2007) 1.53

The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents. J Int AIDS Soc (2013) 1.46

Paediatric European Network for Treatment of AIDS (PENTA) guidelines for treatment of paediatric HIV-1 infection 2015: optimizing health in preparation for adult life. HIV Med (2015) 1.34

Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services. AIDS Patient Care STDS (2009) 1.23

Pregnancy outcomes in adolescents in the UK and Ireland growing up with HIV. HIV Med (2011) 0.99

Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006. Pediatr Infect Dis J (2011) 0.98

Pregnancies in young women with vertically acquired HIV infection in Europe. AIDS (2007) 0.89

Small for gestational age birth outcomes in pregnant women with perinatally acquired HIV. AIDS (2012) 0.87

The second generation of HIV-1 vertically exposed infants: a case series from the Italian Register for paediatric HIV infection. BMC Infect Dis (2014) 0.87

Pregnancy incidence and outcomes in vertically and behaviorally HIV-infected youth. JAMA (2011) 0.86

Impact of HIV-1 infection and pregnancy on maternal health: comparison between perinatally and behaviorally infected young women. Adolesc Health Med Ther (2013) 0.86

Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: a case for lifelong antiretroviral therapy? AIDS (2014) 0.84

Comparison of pregnancies between perinatally and sexually HIV-infected women: an observational study at an urban hospital. Infect Dis Obstet Gynecol (2013) 0.84

Paediatric HIV grows up: recent advances in perinatally acquired HIV. Arch Dis Child (2014) 0.82

Parenting considerations in young adults with perinatally acquired HIV. AIDS Care (2013) 0.81

Sexual and reproductive health in a UK cohort of young adults perinatally infected with HIV. Sex Transm Infect (2013) 0.81

Growth patterns in the first year of life differ in infants born to perinatally vs. nonperinatally HIV-infected women. AIDS (2015) 0.80

UK Mother-to-Child HIV Transmission Rates Continue to Decline: 2012-2014. Clin Infect Dis (2017) 0.78

Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women. Antivir Ther (2012) 0.77

Health and survival of HIV perinatally exposed but uninfected children born to HIV-infected mothers. Curr Opin HIV AIDS (2016) 0.77

Do sexual risk behaviors differ between heterosexual youth infected with HIV perinatally versus sexually? J Adolesc Health (2013) 0.77

Articles by these authors

Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS (2008) 4.48

Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS (2007) 2.80

Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000-2011. AIDS (2014) 2.67

Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis (2007) 2.35

Response to combination antiretroviral therapy: variation by age. AIDS (2008) 2.28

Effect of month of birth on the risk of suicide. Br J Psychiatry (2006) 2.19

Risk of triple-class virological failure in children with HIV: a retrospective cohort study. Lancet (2011) 1.90

Time to undetectable viral load after highly active antiretroviral therapy initiation among HIV-infected pregnant women. Clin Infect Dis (2007) 1.88

Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment. Curr HIV Res (2007) 1.85

Surveillance of congenital cytomegalovirus in the UK and Ireland. Arch Dis Child Fetal Neonatal Ed (2011) 1.53

How active are our children? Findings from the Millennium Cohort Study. BMJ Open (2013) 1.49

CD4 cell response to antiretroviral therapy in children with vertically acquired HIV infection: is it associated with age at initiation? J Infect Dis (2006) 1.46

Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa? AIDS (2005) 1.41

Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centres. Acta Paediatr (2005) 1.39

Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS (2009) 1.36

Estimating the efficacy of interventions to prevent mother-to-child transmission of human immunodeficiency virus in breastfeeding populations: comparing statistical methods. Am J Epidemiol (2003) 1.33

Does highly active antiretroviral therapy increase the risk of congenital abnormalities in HIV-infected women? J Acquir Immune Defic Syndr (2005) 1.32

Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One (2008) 1.32

Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease. Am J Epidemiol (2005) 1.28

Age-related standards for total lymphocyte, CD4+ and CD8+ T cell counts in children born in Europe. Pediatr Infect Dis J (2005) 1.23

Quality control methods in accelerometer data processing: defining minimum wear time. PLoS One (2013) 1.23

Actigraph accelerometer-defined boundaries for sedentary behaviour and physical activity intensities in 7 year old children. PLoS One (2011) 1.22

The double burden of obesity and malnutrition in a protracted emergency setting: a cross-sectional study of Western Sahara refugees. PLoS Med (2012) 1.20

Epistasis in sporadic Alzheimer's disease. Neurobiol Aging (2008) 1.19

Long-term outcomes of congenital cytomegalovirus infection in Sweden and the United Kingdom. Clin Infect Dis (2013) 1.16

Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women. J Reprod Immunol (2006) 1.16

Treating HIV-infected mothers reduces under 5 years of age mortality rates to levels seen in children of HIV-uninfected mothers in rural South Africa. Antivir Ther (2012) 1.13

Triple-class virologic failure in HIV-infected patients undergoing antiretroviral therapy for up to 10 years. Arch Intern Med (2010) 1.12

Reproductive experience of HIV-infected women living in Europe. Hum Reprod (2008) 1.12

Maternal HIV infection associated with small-for-gestational age infants but not preterm births: evidence from rural South Africa. Hum Reprod (2012) 1.12

Higher rates of post-partum complications in HIV-infected than in uninfected women irrespective of mode of delivery. AIDS (2004) 1.10

Nonlinear growth generates age changes in the moments of the frequency distribution: the example of height in puberty. Biostatistics (2007) 1.09

Maternal and infant factors and lymphocyte, CD4 and CD8 cell counts in uninfected children of HIV-1-infected mothers. AIDS (2005) 1.08

Prevention of mother-to-child transmission of HIV infection: Ukraine experience to date. Eur J Public Health (2006) 1.08

25-Hydroxyvitamin D and pre-clinical alterations in inflammatory and hemostatic markers: a cross sectional analysis in the 1958 British Birth Cohort. PLoS One (2010) 1.06

Increasing likelihood of further live births in HIV-infected women in recent years. BJOG (2005) 1.05

Pregnancy and HIV infection: A european consensus on management. AIDS (2002) 1.04

Within and between race differences in lymphocyte, CD4+, CD8+ and neutrophil levels in HIV-uninfected children with or without HIV exposure in Europe and Uganda. Ann Trop Paediatr (2006) 1.03

Crossing the divide: transition care services for young people with HIV-their views. AIDS Patient Care STDS (2011) 1.00

Tuberculosis and HIV co-infection in children. BMC Infect Dis (2014) 1.00

Prevalence of sexually transmitted infections in HIV-1 infected pregnant women in Europe. Eur J Epidemiol (2007) 0.99

Age- and sex-related reference ranges of alanine aminotransferase levels in children: European paediatric HCV network. J Pediatr Gastroenterol Nutr (2009) 0.97

Fertility intentions of HIV-infected women in the United Kingdom. AIDS Care (2011) 0.97

Does exposure to antiretroviral therapy affect growth in the first 18 months of life in uninfected children born to HIV-infected women? J Acquir Immune Defic Syndr (2005) 0.96

Incidence, patterns, and predictors of repeat pregnancies among HIV-infected women in the United Kingdom and Ireland, 1990-2009. J Acquir Immune Defic Syndr (2012) 0.96

National Guidelines for the prevention of mother-to-child transmission of HIV across Europe - how do countries differ? Eur J Public Health (2013) 0.95

Use of zidovudine-sparing HAART in pregnant HIV-infected women in Europe: 2000-2009. J Acquir Immune Defic Syndr (2011) 0.94

Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors. J Acquir Immune Defic Syndr (2012) 0.94

Maternal cognitions and mother-infant interaction in postnatal depression and generalized anxiety disorder. J Abnorm Psychol (2012) 0.93

Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project. Neurobiol Aging (2010) 0.93

Who, then what? The need for interventions to help young people with perinatally acquired HIV disclose their HIV status to others. AIDS (2014) 0.92

Eating habits and attitudes among 10-year-old children of mothers with eating disorders: longitudinal study. Br J Psychiatry (2006) 0.92

Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy. Jpn J Clin Oncol (2004) 0.92

Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. AIDS (2013) 0.92

Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe. Antivir Ther (2011) 0.92

Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker. J Clin Invest (2014) 0.92

The association between ethnicity and late presentation to antenatal care among pregnant women living with HIV in the UK and Ireland. AIDS Care (2012) 0.91

Cell-free (RNA) and cell-associated (DNA) HIV-1 and postnatal transmission through breastfeeding. PLoS One (2012) 0.91

Predictors of non-response in a UK-wide cohort study of children's accelerometer-determined physical activity using postal methods. BMJ Open (2013) 0.91

When t-tests or Wilcoxon-Mann-Whitney tests won't do. Adv Physiol Educ (2010) 0.91

Rubella susceptibility among pregnant women in North London, 1996-1999. J Public Health Med (2002) 0.91

Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS (2013) 0.90

Intussusception incidence among infants in the UK and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance study. Vaccine (2013) 0.90

Intimate relationships in young adults with perinatally acquired HIV: partner considerations. AIDS Care (2012) 0.90

Impact of expanded access to combination antiretroviral therapy in pregnancy: results from a cohort study in Ukraine. Bull World Health Organ (2013) 0.89

Antiretroviral therapy during pregnancy and the risk of an adverse outcome. N Engl J Med (2003) 0.89

Predictors of retinochoroiditis in children with congenital toxoplasmosis: European, prospective cohort study. Pediatrics (2008) 0.89

Replication by the Epistasis Project of the interaction between the genes for IL-6 and IL-10 in the risk of Alzheimer's disease. J Neuroinflammation (2009) 0.89

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA. BMC Infect Dis (2007) 0.89

Pregnancies in young women with vertically acquired HIV infection in Europe. AIDS (2007) 0.89

Antiretroviral therapy in pregnancy: balancing the risk of preterm delivery with prevention of mother-to-child HIV transmission. Antivir Ther (2010) 0.89

Treatment and disease progression in a birth cohort of vertically HIV-1 infected children in Ukraine. BMC Pediatr (2010) 0.88

Cervical screening within HIV care: findings from an HIV-positive cohort in Ukraine. PLoS One (2012) 0.88

A population-based study of newly diagnosed epilepsy in infants. Epilepsia (2012) 0.88

The dopamine β-hydroxylase -1021C/T polymorphism is associated with the risk of Alzheimer's disease in the Epistasis Project. BMC Med Genet (2010) 0.88

Mother-to-child transmission risk is increased among HIV-infected pregnant women in Ukraine with serological test results positive for syphilis. Clin Infect Dis (2008) 0.87

Short- and long-term immunological and virological outcome in HIV-infected infants according to the age at antiretroviral treatment initiation. Clin Infect Dis (2011) 0.87

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland. AIDS (2014) 0.87

Use of neonatal antiretroviral prophylaxis for prevention of mother-to-child transmission of HIV is decreasing in Western Europe. Clin Infect Dis (2009) 0.86

Contribution of respiratory tract infections to child deaths: a data linkage study. BMC Public Health (2014) 0.86

Post-licensing safety of fosamprenavir in HIV-infected children in Europe. Pharmacoepidemiol Drug Saf (2014) 0.86